Texas Border Business
- Advertisement -
Suman Sirimulla, Ph.D., assistant of pharmaceutical sciences at UTEP, is leading a group of experimental researchers to virtually develop the molecular structure of a protease inhibitor that would target the coronavirus, which causes COVID-19, a respiratory illness that can spread from person to person.
- Advertisement -
